ÂÜÀòÂÒÂ×

Jeffrey Lacey, CPA, currently serves as the Senior Director of Accounting & Finance at NextPoint Therapeutics, Inc., a position held since May 2023. Previously, Jeffrey held senior director roles at Kira Pharmaceuticals and Yumanity Therapeutics. Jeffrey gained experience as the SEC Reporting Manager at Foundation Medicine and as Assistant Controller at Turbonomic. A background in consulting was developed at CFGI, followed by a role as a Credit Risk Analyst at Morgan Stanley, where extensive credit analysis was performed within the healthcare sector. Jeffrey began their career as an Experienced Audit Associate at PricewaterhouseCoopers. Educational qualifications include a Master of Science in Accounting and a Bachelor of Business Administration in Accounting, both obtained from the Isenberg School of Management at UMass Amherst.